These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11809648)

  • 1. First trial of the HIV-1 vaccine in Africa: Ugandan experience.
    Mugerwa RD; Kaleebu P; Mugyenyi P; Katongole-Mbidde E; Hom DL; Byaruhanga R; Salata RA; Ellner JJ;
    BMJ; 2002 Jan; 324(7331):226-9. PubMed ID: 11809648
    [No Abstract]   [Full Text] [Related]  

  • 2. Uganda pioneers ALVAC -- and informed consent. Vaccine trials.
    Epstein H; Nsubuga L
    AIDS Anal Afr; 1997 Feb; 7(1):2-3. PubMed ID: 12292058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV vaccine trials for Uganda?
    Epstein H
    Lancet; 1994 Apr; 343(8902):910. PubMed ID: 7908365
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uganda gets set for vaccine trials, but the ethical debate continues.
    AIDS Anal Afr; 1997 Apr; 7(2):1. PubMed ID: 12290340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV vaccines: the Uganda experience.
    Mugyenyi PN
    Vaccine; 2002 May; 20(15):1905-8. PubMed ID: 11983242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uganda will provide HIV vaccine subjects in return for services. Conference coverage (NCVDG).
    Denoon DJ
    AIDS Wkly Plus; 1996 Mar; ():10-1. PubMed ID: 12346962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of treatment in HIV-1 vaccine trials in developing countries.
    Fitzgerald DW; Pape JW; Wasserheit JN; Counts GW; Counts GW; Corey L
    Lancet; 2003 Sep; 362(9388):993-4. PubMed ID: 14513852
    [No Abstract]   [Full Text] [Related]  

  • 10. Thorny issues in the ethics of AIDS vaccine trials.
    Berkley S
    Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical challenges of HIV vaccine trials in less developed nations: conflict and consensus in the international arena.
    Bayer R
    AIDS; 2000 May; 14(8):1051-7. PubMed ID: 10853988
    [No Abstract]   [Full Text] [Related]  

  • 12. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
    Yearby R
    De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
    [No Abstract]   [Full Text] [Related]  

  • 14. Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa.
    Lindegger G; Quayle M; Ndlovu M
    Health Educ Behav; 2007 Feb; 34(1):108-23. PubMed ID: 16740504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical considerations in vaccine trials with special reference to candidate HIV vaccines.
    Fast PE; Sawyer LA; Wescott SL
    Pharm Biotechnol; 1995; 6():97-134. PubMed ID: 7551256
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV immunology: what lessons can we learn from recent vaccine trials?
    Kelleher P
    J HIV Ther; 2010 Mar; 15(1):2-5. PubMed ID: 21180231
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
    Baden LR; Karita E; Mutua G; Bekker LG; Gray G; Page-Shipp L; Walsh SR; Nyombayire J; Anzala O; Roux S; Laher F; Innes C; Seaman MS; Cohen YZ; Peter L; Frahm N; McElrath MJ; Hayes P; Swann E; Grunenberg N; Grazia-Pau M; Weijtens M; Sadoff J; Dally L; Lombardo A; Gilmour J; Cox J; Dolin R; Fast P; Barouch DH; Laufer DS;
    Ann Intern Med; 2016 Mar; 164(5):313-22. PubMed ID: 26833336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past, present and future of HIV vaccine trials in developing countries.
    Esparza J; Osmanov S; Pattou-Markovic C; Touré C; Chang ML; Nixon S
    Vaccine; 2002 May; 20(15):1897-8. PubMed ID: 11983240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Vaccine Trial participation in South Africa - an ethical assessment.
    Moodley K
    J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV vaccine trials in Africa.
    Sandström E; Birx D
    AIDS; 2002; 16 Suppl 4():S89-95. PubMed ID: 12699005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.